Welltower 10-Qquarter ended 2026-06-30

Positive

Outpatient medical sales fund seniors-housing acquisitions including Amica, while occupancy and pricing gains drive same-store growth.

Filed 2026-07-28 16:07 ET

Key figures · Q2 FY2026 · period ended 2026-06-30

  • Revenue$3.5BYoY +39.1%QoQ +5.7%
  • Operating income— Not reported
  • Net income$445.0MYoY +47.4%QoQ −38.9%
  • Total assets$69.9BYoY +25.1%QoQ +3.9%
  • Total debt— Unavailable
  • Shareholders' equity$46.4B1YoY +29.3%QoQ +6.0%
  • Tangible book value$45.2B2YoY +29.0%QoQ +5.9%
Notes (2)
  1. Shareholders' equity: About the summary: The summary's $47.4B is total equity including noncontrolling interests; shareholders' equity attributable to the company's own shareholders is $46.41B.
  2. Tangible book value: From the notes to the financial statements; the balance sheet does not present this as a separate line.

How this filing reads

  • Health+0.1H1 FCF was $918M against $1.05B dividends, while the $6.25B revolver covers $3.01B 2027 maturities.
  • Momentum+0.7H1 FFO per share rose 21%, and same-store NOI grew 17% in Q2.
  • Outlook+0.3Occupancy rose to 87.6%, with over $5B of H2 seniors-housing acquisitions closed or expected.

Executive Summary

Welltower is becoming a more concentrated seniors-housing owner and operator, recycling outpatient medical assets into acquisitions across Canada, the U.K. and the U.S. Q2 revenue grew 39%, while seniors-housing same-store growth demonstrated that expansion was not solely acquisition-driven. Earnings improved substantially, but property-sale gains and a Canadian tax benefit amplified GAAP results, while equity issuance diluted growth per share. The investment thesis rests on sustaining occupancy and pricing gains and earning attractive returns on a rapidly enlarged portfolio; increased operator concentration, acquisition execution and dependence on external capital are the principal threats.

Key Financial Highlights

Metric Q2 2026; H1 where applicable Investor interpretation
Revenue Q2 $3.54B, +39% Y/Y; H1 $6.90B, +39% Acquisitions and resident-fee growth outweighed medical-property sales.
GAAP net income attributable to common stockholders Q2 $445M, +47%; H1 $1.17B, +110% Transaction gains materially boosted H1 earnings.
Diluted EPS Q2 $0.61 vs $0.45; H1 $1.63 vs $0.85 Share issuance tempered earnings growth per share.
Funds from operations, attributable to common stockholders, non-GAAP Q2 $1.15B, +40%; H1 $2.14B, +34%; per share $1.56 and $2.92 Excludes real estate gains and depreciation; per-share growth was 26% and 21%.
EBITDA, non-GAAP Q2 $1.32B, +40%; H1 $2.90B, +59% Supplemental earnings measure, not cash available for distributions.
Total assets; total equity 6/30/2026: $69.9B; $47.4B, up 3.8% and 10% from year-end Equity funding supported portfolio expansion.
Debt, carrying value; net debt $17.7B; $16.1B, +18% Q/Q Cash deployment increased net leverage despite equity raising.
  • Cash conversion: H1 OCF $1.67B, +22%, vs consolidated net income $1.22B; capital spending $756M → FCF $918M. FCF was below $1.05B of dividends, leaving acquisitions and other investment needs dependent on additional funding.
  • Earnings quality: H1 real estate disposition and controlling-interest gains $519M vs $66.6M; these gains explain part of the gap between GAAP earnings growth and operating growth.
  • Tax accounting: $71.3M deferred-tax benefit from reducing a Canadian subsidiary’s valuation allowance supported Q2 earnings; this was not operating improvement.
  • Capital issuance and compensation: H1 at-the-market net proceeds $4.45B; shares outstanding increased 22.4M, or 3.2%, to 719M. No authorized-program repurchases occurred in Q2; the trailing-12-month adjusted EBITDA reconciliation included a $1.56B stock-based compensation adjustment vs $85.8M.
  • Operating mix: Resident fees represented 84% of H1 revenue. Q2 same-store net operating income at Welltower’s share increased 17%, supporting growth beyond purchased assets.

Business Developments

  • Portfolio repositioning: Seniors Housing Operating and Triple-net generated 97% of Q2 segment net operating income, versus 84% a year earlier; outpatient medical sales reduce diversification while concentrating resources on seniors housing.
  • Acquisition deployment: H1 property acquisitions and joint-venture investments totaled $7.15B in book amount across 151 properties, at a 6.0% weighted capitalization rate. The $2.95B Amica acquisition added 34 Canadian communities and interests in four unconsolidated properties; management announced more than $5B of seniors-housing acquisitions closed or expected in H2.
  • Medical-property exit: 311 of 319 properties in the planned ≈$7.2B gross sale had been disposed of by 6/30/2026. Expected net proceeds of ≈$6.0B, after retained preferred and profits interests, provide reinvestment capital rather than a complete economic exit.

Risk Assessment

  • Concentration: Five leading relationships generated 35% of segment net operating income vs 20%, and the U.K. contributed 24% vs 13%; operator distress or adverse local conditions now affect a larger share of results.
  • Acquisition execution: Rapid deployment increases integration and operator-transition exposure; Seniors Housing Operating Q2 common-stockholder earnings fell despite 61% net operating income growth as depreciation and other expenses increased.
  • Funding and refinancing: Cash and equivalents fell to $1.97B, with debt principal maturities of $3.01B in 2027; the undrawn $6.25B revolver provides liquidity, but investment returns depend on capital availability and cost.
  • Credit: Five deteriorated loans carried $134M, including $125M of Genesis notes; Chapter 11 recoveries depend on collateral and bankruptcy outcomes.
  • Rates and currency: +100bp → annual interest expense +$28.9M on variable-rate debt after swaps; foreign acquisitions also expose earnings and hedge settlements to exchange-rate movements.

A 10-Q does not have to restate the risk factors in the annual report. Full list: the company's 10-Ks on SEC.

Strategic Outlook and Investor Actionables

Management is betting that acquisitions, renovations and occupancy-led growth can replace outpatient medical income and deliver rising dividends and returns per share. The opportunity is operational improvement across a larger seniors-housing platform; the threat is that financing, transition costs and dilution absorb those gains.

  • Seniors-housing operations: Q2 occupancy was 87.6% vs 85.6%, with same-store net operating income growth of 21%. Subsequent gains would validate pricing and occupancy momentum; slowing growth alongside rising costs would weaken it.
  • Acquisition returns: Track the $2.95B Amica investment and management’s more-than-$5B H2 acquisition program. Growing acquired-property revenue and income would support the thesis; impairments, transitions or disposals would challenge it.
  • Triple-net economics: Q2 same-store net operating income grew 7.6%, with H1 rent increases averaging 4.4% across 26 leases. Continued rent growth supports contractual returns; tenant distress or stalled revenue-linked escalators would undermine them.
  • Per-share funding discipline: H1 funds from operations per share grew 21%, while FCF fell short of dividends. Improving per-share results and cash coverage would support expansion; rising leverage without corresponding per-share gains would indicate dilution is absorbing returns.

Figures are computed from the filing's XBRL data; the summary and scores are written by an AI model reading the filing.

Model 006 · prompt bdad6d7239

Feedback